central
Navigation Links
central at medicine technology
When Volume Matters, Immunoassay Systems Deliver
... to occur at the bedside or physicians office, the central laboratory is hardly threatened with extinction. National volume data suggest that medium and large labs are busier than ever before, and the huge range of their capabilities, gold standard reliability and ability to handle very large volumes of test...Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse
...en containers which are to be filled and sent to a central laboratory, where the actual testing is done. The price of the kit includes the testing. In the drugs of abuse category, several firms produce test kits that can be used in point of care settings to monitor drug free status or in the pre-employment ...Genetic Analysis Systems Enter the Clinical Mainstream
...ortant as supporting evidence for the diagnosis of central nervous system (CNS) disorders. This kit is useful in the diagnosis of multiple sclerosis and other CNS diseases. Each kit contains 5 gels, anolyte and catholyte solutions, ammonium nitrate, silver nitrate, tungstosilicic acid, formaldehyde, precut w...Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
...y whole blood provide an attractive alternative to central lab testing. Although the advantages of rapid TAT must be balanced with the need for stringent quality control (QC), many POC analyzers have internal QC systems, and manufacturers provide external controls appropriate to each assay. Biosite Inc., Re...New Point-of-Care Methods to Measure Coronary and Cerebrovascular Risk
...organs, which may be acute or chronic. Despite the central role of the artery in coronary and cerebrovascular disease, it has not been practical to screen every patient by directly assessing the arteries. Direct assays such as carotid ultrasound, coronary angiography, computed tomography angiography (CTA), ...New Quality Control Systems for Every Laboratory Application
...results can be transmitted electronically to their central data management system, and the QC report can be retrieved and reviewed within minutes. Assays can be monitored for linearity. QC results can be compared with those from other customers using similar methods and equipment. Multiple assays can be comp...Immunoassay Systems - Your Laboratory Workhorse
... to occur at the bedside or physicians office, the central laboratory is hardly threatened with extinction. National volume data suggest that medium and large labs are busier than ever before, and the huge range of their capabilities, gold standard reliability and ability to handle very large volumes of test...Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
...gas panels can be ordered on blood drawn through a central venous line to estimate cardiac output. Blood gas ...ral hours, for the results from a more traditional central laboratory-based analyzer. By the time those results become available, the condition of the patient ...Optimizing Quality Control Data Management
...rison program, laboratories submit their data to a central database and receive back reports comparing their results statistically to other laboratories in defined consensus groups running the same or similar tests. In this manner, a laboratory can compare its performance to available consensus groups to de......ndpoints were adjudicated by ablinded, independent central adjudication committee. The study wasnot powered to show a dose response with PRT054021 or efficacy ofPRT054021 versus enoxaparin. About PRT054021 -- Portola's Factor Xa Inhibitor PRT054021 is an oral Factor Xa inhibitor, an anticoagulantinitially ...Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
...ment ofinnovative gene therapies for the brain and central nervous system,announced today that the company wi...oprietary treatments for disorders ofthe brain and central nervous system utilizing gene therapies. TheCompany's initial development efforts are focused on gen......vascular,thrombosis, oncology, metabolic diseases, central nervous system,internal medicine and vaccines. Sanofi-aventis is listed in Parisand in New York . Forward Looking Statements This press release contains forward-looking statements asdefined in the Private Securities Litigation Reform Act of 1995, a......dergoing TKR. Garry Neil, MD, group president for central nervous system andinternal medicine research & development at Johnson &Johnson Pharmaceutical Research and Development commented: "Webelieve rivaroxaban could alter the landscape of antithrombotictherapy. An effective once-daily oral anticoag...Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
...rolein or chloroacetaldehyde which causebladder or central nervous system toxicities. ZIO-201 continues ina phase I trial in diverse cancers exploring maximum tolerated doseat alternate schedules. A phase II trial in advanced sarcomacontinues to enroll patients. Trials in lymphoma and pediatriccancers are in...Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29
...he treatment ofprevalent, chronic diseases such as central nervous systemdisorders, addiction and diabetes. Alkermes' headquarters are inCambridge, Massachusetts, and it operates research andmanufacturing facilities in Massachusetts and Ohio. Certain statements set forth above may constituteforward-looking ......cting with specific opioidreceptors located in the central nervous system (CNS) - the brainand spinal cord. H...ds onperipheral receptors without interfering with central nervoussystem pain relief. Methylnaltrexone is being developed insubcutaneous and oral forms to trea......he body to produceinsulin, a hormone which plays a central role in the regulation ofblood sugar levels. New data from a separate pharmacologic studyreported today in an oral presentation revealed that, when used incombination in healthy adults, the different mechanisms of actionof JANUVIA and metformin had a...... development and on the market act onpredominantly central nervous system receptor targets that are alsofound in the GI tract. Many show potentially serious CNS sideeffects. Our small molecule ghrelin agonists target a receptor thatis more directly involved with regulating gastrointestinalmotility." About G......oraltherapy for type 2 diabetes that acts upon the central nervoussystem (CNS) to impact peripheral metabolism. The Phase IIIb trialwas conducted in response to an approvable letter from the FDArequesting additional data on Cycloset(TM)'s cardiovascularsafety. The double-blind, multi-center trial's 3,070 pa......rodusquemineselectively inhibits PTP-1B, an enzyme central to controlling thefunction of both the leptin and ..., protein tyrosine phosphatase1B (PTP-1B), that is central to both insulin and leptin pathways.By inhibiting PTP-1B, MSI-1436 is expected to decrease appetite ......of cardiovascular, gastrointestinal,infectious and central nervous system diseases through itssubsidiaries -- Laboratorios Belmac, Laboratorios Davur,Laboratorios Rimafar and Bentley Pharmaceuticals Ireland. Bentleyalso manufactures and markets active pharmaceutical ingredientsthrough its subsidiary, Bentley...AMIA Announces 2008 Summit on Translational Bioinformatics
...y visible role oftranslational bioinformatics as a central component of our nationalbiomedical research enterprise, the opportunities for AMIA and itsmembership to assume a leadership role in this critical area aresignificant," comments Philip R. Payne, MD, Assistant Professor ofBiomedical Informatics, Ohio ......oprietary treatments for disorders ofthe brain and central nervous system utilizing gene therapies. TheCompany's initial development efforts are focused on gene therapyfor treating Parkinson's disease, epilepsy and otherneurodegenerative and metabolic disorders. Neurologix's coretechnology, "NLX," is current......ts of the studyin the poster discussion session on central nervous system tumorsat the 43rd Annual Meeting of... Efficacy endpoints were tumorresponse assessed by central blinded MRI reading and survival. At29 international clinical centers 134 evaluable patients (39 wit......opharmaceutical company focused on thetreatment of central nervous system disorders with an initial focuson o...rmaceutical product candidates forthe treatment of central nervous system disorders, with an initialfocus on obesity. Orexigen's lead combination product candi...Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
...iscoveryof new therapies targeting diseases of the central nervoussystem. <p style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: 12pt; mso-layout-grid-align: none">Millipore’s Bioscience Division provides innovative tools,services and biological reagents that drive advancements inbiomedical and academi......proteintyrosine phosphatase 1B (PTP-1B). PTP-1B is central to controllingthe function of both the leptin and insulin pathways. By inhibitingPTP-1B, MSI-1436 is expected to decrease appetite and normalizeblood sugar. Trodusquemine has produced consistent, sustainableweight loss in a variety of animal models a......a), a protein that when produced in excess,plays a central role in the inflammatory responses ofimmune-mediated diseases. To date, HUMIRA has been approved in 67countries with more than 190,000 people worldwide currently treatedwith HUMIRA. Clinical trials are currently under way evaluating thepotential of H......ritis, kidney failure,heart and lung inflammation, central nervous system abnormalities,inflammation of the blood vessels, and blood disorders. For moreinformation on lupus, visit the Lupus Foundation of America at www.lupus.org ,the European Lupus Erythematosus Federation at <a target="_blank"href="http...Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
...eutical andbiotechnology products in the fields of central nervous systemdisorders, allergy/respiratory diseases, immune and inflammatorydisorders and oncology. UCB focuses on securing a leadingposition in severe disease categories. Employing more than 8,400 people inover 40 countries, UCB achieved revenue ...... care, infectious disease,gastrointestinal health, central nervous system, inflammation,transplantation, hemophilia, oncology, vaccines and nutritionalproducts. Wyeth is one of the world's largest research-drivenpharmaceutical and health care products companies. It is a leaderin the discovery, development, ...... task. The videotapes wereanalyzed and scored at a central laboratory. Raters were blindedwith regard to trea...as SUPPRELIN(R) LA, which was recentlyapproved for central precocious puberty. The Indevus developmentpipeline contains multiple compounds within the Company's...Gabapentin Shown Effective for Fibromyalgia Pain
...searchsuggests it is related to a problem with the central nervoussystems processing of pain. As with some ot...s,there is no physical evidence of inflammation or central nervoussystem damage. Although gabapentin has little, if any, effect on acute pain, ithas shown a r......idates addresstherapeutic markets that include the central nervous system,cardiovascular disorders, inflammation and infectious diseases.AVANIR currently markets FazaClo(R), the only orally-disintegratingformulation of clozapine for the management of severely illschizophrenic patients who fail to respond ade......ialization of clinical-stageproduct candidates for central nervous system disorders. Thecompany has three product candidates in clinical development.Vanda's lead product candidate, iloperidone, is a compound for thetreatment of schizophrenia and bipolar disorder and has recentlycompleted its Phase III progra......cuses on developing novel drugs for diseasesof the central nervous system. Teva's U.S. innovative product marketing subsidiary, TevaNeuroscience, Inc., promotes AZILECT in the United States. AZILECTis a registered trademark of Teva Pharmaceutical IndustriesLtd. Please visit <a target="_blank" href="htt...Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study
...DDP733,which targets the GI motility abnormalities central to GERD, hasdemonstrated a statistically significant reduction in the number ofreflux events at a dose of 0.5 mg in this trial. We are nowplanning a larger Phase 2 study in GERD patients, where we willfurther build on these very promising results.&r...Dynogen Reports Positive Results in Phase 1B GERD Study
...DDP733, which targets the GI motilityabnormalities central to GERD, has demonstrated a statisticallysignificant reduction in the number of reflux events at a dose of0.5 mg in this trial. We are now planning a larger Phase 2 study inGERD patients, where we will further build on these very promisingresults." ......opharmaceutical company focused on thetreatment of central nervous system disorders with an initial focuson o...rmaceutical product candidates forthe treatment of central nervous system disorders, with an initialfocus on obesity. Orexigen's lead combination product candi...Indevus Reports Positive Data From Phase III NEBIDO Trial
...as SUPPRELIN(R) LA, which was recentlyapproved for central precocious puberty. The Indevus developmentpipeline contains multiple compounds within the Company's coretherapeutic areas in addition to several partnered or partnerableprograms. The most advanced compounds in development includeSANCTURA XR(TM), the......e. CGRP andits receptors are found in areas of the central and peripheralnervous system that are important for the transmission of migrainepain. During migraine attacks, CGRP activates these receptors andfacilitates the transmission of pain impulses. MK-0974 blocks thebinding of CGRP to receptors within thes...IDM Pharma Presents Preliminary Results from Phase II UVIDEM Melanoma Vaccine Clinical Trial
...vascular,thrombosis, oncology, metabolic diseases, central nervous system,internal medicine and vaccines. Sanofi-aventis is listed in Parisand in New York . Forward-Looking Statements This press release includes and the presentation described inthis press release will include forward-looking statements tha......vascular,thrombosis, oncology, metabolic diseases, central nervous system,internal medicine and vaccines. Sanofi-aventis is listed in Parisand in New York . Forward Looking Statements This press release contains forward-looking statements asdefined in the Private Securities Litigation Reform Act of 1995, a...NovaDel Announces Positive Data from Two Studies Comparing Zolpidem Oral Spray to Ambien Tablets
..., insomnia, migraine headaches anddisorders of the central nervous system. NovaDel plans to developthese and other products independently and through collaborativearrangements with pharmaceutical and biotechnology companies. Tofind out more about NovaDel Pharma Inc. (AMX: NVD), visit ourwebsite at www.novade......in tumorsaccount for as many as 90% of all primary central nervous systemtumors.(4) The commonest type of pri... 2005; 55:74-108. 4. Levin et al. Neoplasms of the central nervous system. In DeVitaVT Jr, Hellman S, Rosenberg SA, eds: Cancer: Principles andPractice of Onco......vascular,thrombosis, oncology, metabolic diseases, central nervous system,internal medicine and vaccines. Sanofi-aventis is listed in Parisand in New York . Forward Looking Statements This press release contains forward-looking statements asdefined in the Private Securities Litigation Reform Act of 1995, a......vascular,thrombosis, oncology, metabolic diseases, central nervous system,internal medicine and vaccines. Sanofi-aventis is listed in Parisand in New York . Forward Looking Statements This press release contains forward-looking statements asdefined in the Private Securities Litigation Reform Act of 1995, a......capital today. Multiplesclerosis, a disease of the central nervous system that affects400,000 people in the United States, challenges patients, carepartners and healthcare professionals in many ways. The meetingprovides specialists in the fields of MS healthcare, research,advocacy, community service and educ...IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at 2007 ASCO Annual Meeting
...vascular,thrombosis, oncology, metabolic diseases, central nervous system,internal medicine and vaccines. Sanofi-aventis is listed in Parisand in New York . Forward-Looking Statements This press release includes and the presentation described inthis press release will include forward-looking statements tha...Hemispherx Presents Potential Avian Influenza Treatment Breakthrough at Paris Conference
...d the resulting intenseinflammatory responses, are central to influenza H5N1 pathogenesis.The focus of clinical management should be on preventing thisintense cytokine response, by early diagnosis and effectiveantiviral treatment." To study the effects of Alferon-LDO, researchers administeredmacaque subje......mercialization ofinnovative treatments for cancer, central nervous system disorders,sexual dysfunction and ot...andcommercialize innovative treatments for cancer, central nervoussystem disorders, sexual dysfunction and other unmet medical needs.Rexahn's compounds are des...Data to be Presented at ASCO 2007 Highlights sanofi-aventis Commitment to Cancer Care and Research
...vascular,thrombosis, oncology, metabolic diseases, central nervous system,internal medicine and vaccines. Sanofi-aventis is listed in Parisand in New York . Forward Looking Statements This press release contains forward-looking statements asdefined in the Private Securities Litigation Reform Act of 1995, a...MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
...targeting IL-9 andpreclinical data demonstrating a central role for IL-9 in thepathology of asthma. These data, along with preclinical resultsfrom other respiratory inflammation programs within MedImmune'spipeline, were presented during the American Thoracic Society (ATS)2007 International Conference, held M......the activity of serotonin andnorepinephrine in the central nervous system. Duloxetine is approved for the treatment of depression and diabeticperipheral neuropathic pain in many countries and is approved insome countries for the treatment of stress urinary incontinence.Duloxetine is approved only for adults......HDtreatments, guanfacine extended release is not a central nervoussystem stimulant or a controlled substance and does not appear tohave a mechanism for potential abuse or dependence. It has been shown that guanfacine HCI binds selectively to thealpha 2A adrenergic cell receptors that are found throughout th......of cardiovascular, gastrointestinal,infectious and central nervous system diseases through itssubsidiaries -- Laboratorios Belmac, Laboratorios Davur,Laboratorios Rimafar and Bentley Pharmaceuticals Ireland. Bentleyalso manufactures and markets active pharmaceutical ingredientsthrough its subsidiary, Bentley......treatment of Functional Somatic Syndromesand other central nervous system conditions, including fibromyalgias...trategy involves acquiring/in-licensingundervalued central nervous system active compounds and developingthem for new indications. For more information about ...... care, infectious disease,gastrointestinal health, central nervous system, inflammation,transplantation, hemophilia, oncology, vaccines and nutritionalproducts. Wyeth is one of the world's largest research-drivenpharmaceutical and health care products companies. It is a leaderin the discovery, development, ......eutical andbiotechnology products in the fields of central nervous systemdisorders, allergy/respiratory diseases, immune and inflammatorydisorders and oncology. UCB focuses on securing a leading positionin severe disease categories. Employing more than 8,400 people inover 40 countries, UCB achieved revenue o......a), a protein that when produced inexcess, plays a central role in the inflammatory responses ofimmune-mediated diseases. To date, HUMIRA has been approved in 67countries with more than 180,000 people worldwide currently treatedwith HUMIRA. Clinical trials are currently under way evaluating thepotential of H...Other ContentsjointjointjointjointjointjointjointjointkaryotypekeratinkeratinkeratinkidneykidneykidneykidneykidneykidneykidneykidneykidneykinesiologykinetickinetickinetickinetickineticOther TagsOutbreakOutbreakOvulation
(Date:7/23/2008)...io Wealthy nations willing to collectively spend ...on of roughly half a billion metric tons of carbon...rch suggests. , It would take about that much m...restation in the world, one of the top contributor...e. , If adopted, this type of program could have...
(Date:7/23/2008)...d summit" will bring together internationally reno....S., Russia, China, Japan, Australia and India to... to Aug. 2. , "We are bringing together the w...e," said summit organizer J. William Schopf, found...s and Planetary Physics, Center for the Study of E...
(Date:7/23/2008)...t the National Institute of Standards and Technolo...e formation of clumps of proteins in protein-based...rifies the conditions under which scientists can b...asuring the formation of protein aggregates, a maj...l and safety in biologic drug manufacturing. , P...
(Date:7/23/2008)... scientists who set out to study sex pheromones in...nes also controls a stage in the worms, life cycle...published in Nature online on July 23, represent...e been linked through so-called small molecules. ...eins as the major players in an organism,s biology...
Breaking Biology News(10 mins):Paying to save tropical forests could be a way to reduce global carbon emissions 2Paying to save tropical forests could be a way to reduce global carbon emissions 3Paying to save tropical forests could be a way to reduce global carbon emissions 4UCLA 'world summit' to explore ancient life on Earth, and beyond 2NIST trumps the clumps: Making biologic drugs safer 2Sex and lifespan linked in worms 2Under the Canopy 28R 29 Turns a New Leaf With 2008 Spring Season 13696 1Under the Canopy 28R 29 Turns a New Leaf With 2008 Spring Season 13696 2Medco Tops Fortunes List of Americas Most Admired Companies in its Industry 13692 1Medco Tops Fortunes List of Americas Most Admired Companies in its Industry 13692 2Medco Tops Fortunes List of Americas Most Admired Companies in its Industry 13692 3Biking Walking Best for New Knees 13688 1Biking Walking Best for New Knees 13688 2Biking Walking Best for New Knees 13688 3ProMetic reports continued positive data in PBI 1402 phase II trial in chemotherapy induced anemia 3764 1ProMetic reports continued positive data in PBI 1402 phase II trial in chemotherapy induced anemia 3764 2ProMetic reports continued positive data in PBI 1402 phase II trial in chemotherapy induced anemia 3764 3(Date:7/25/2008)... to benefit ALS Therapy Alliance to be presented a...ht, WOONSOCKET, R.I., July 25 /PRNewswire/ -- CVS...ised a record-breaking $4.4 million in just 21 day... for ALS research. This is,the seventh year of the...sed more than $15 million for ALS research. This y...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... New program delivers immediate co...[24-hour telephone access to language interpreters...g multilingual solutions. , ...LLE® http://www.lle-inc.com/index.html [(Lan...ider of interpretation, translation, and language ...
(Date:7/25/2008)... Whether you are an Olympian, Prof..., there are Five Things You Need to Know about Hyd....C. Spine and Sports Center , ...-- America,s premier athletes are heading to Beiji...ng and sacrifice in the hopes of capturing an Olym...
Breaking Medicine News(10 mins):Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:People With GERD More Likely to Develop Asthma 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5[0] CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign[0] People With GERD More Likely to Develop Asthma[0] LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program[0] Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know
OsteocyteOstiumOutbreakOverlappingOutbreedingOverhangOviductOvulationOviductsOvuleOvuliferousOvulesOxygenatedPachytene
Other Tagsworthwhile 2worthwhile 3testicular 2testicular 3snacks 2snacks 3macular 2macular 3macular 4macular 5fast 2fast 3fast 4fast 5fast 6fast 7fast 8fast 9fast 10healthier 2gone 2gone 3gone 4keeping 2keeping 3keeping 4keeping 5keeping 6| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |